Загрузка...
Current Status of Biosimilar Growth Hormone
As the first wave of biopharmaceuticals is set to expire, biosimilars or follow-on protein products (FOPPs) have emerged. The regulatory foundation for these products is more advanced and better codified in Europe than in the US. Recent approval of biosimilar Somatropin (growth hormone) in Europe an...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2777019/ https://ncbi.nlm.nih.gov/pubmed/19956705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/370329 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|